BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18204782)

  • 1. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
    Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
    Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tubulin polymerization inhibitor derived from thalidomide: implications for anti-myeloma therapy.
    Kizaki M; Hashimoto Y
    Curr Med Chem; 2008; 15(8):754-65. PubMed ID: 18393844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulin-polymerization inhibitors derived from thalidomide.
    Inatsuki S; Noguchi T; Miyachi H; Oda S; Iguchi T; Kizaki M; Hashimoto Y; Kobayashi H
    Bioorg Med Chem Lett; 2005 Jan; 15(2):321-5. PubMed ID: 15603947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells.
    Sato M; Sagawa M; Nakazato T; Ikeda Y; Kizaki M
    Int J Oncol; 2007 Jun; 30(6):1453-9. PubMed ID: 17487366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
    Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
    Kawano T; Agata N; Kharbanda S; Avigan D; Kufe D
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):329-35. PubMed ID: 16830153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
    Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
    Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
    Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
    Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
    Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors.
    Beckers T; Reissmann T; Schmidt M; Burger AM; Fiebig HH; Vanhoefer U; Pongratz H; Hufsky H; Hockemeyer J; Frieser M; Mahboobi S
    Cancer Res; 2002 Jun; 62(11):3113-9. PubMed ID: 12036922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
    Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM
    Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.
    Nakamura S; Kobayashi M; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Hayashi H; Ohnishi K
    Leuk Res; 2006 Feb; 30(2):123-35. PubMed ID: 16046235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
    J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis inhibitors derived from thalidomide.
    Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.